Groundbreaking new cystic fibrosis drug offers Montreal teacher a new lease on life
Trikafta was approved for use in Canada last June. In late September, four provincial governments — Quebec, Ontario, Saskatchewan and Alberta — announced they would cover the treatment's hefty price tag of around $300,000. For people like Chelsea Gagnon, that's welcome news.
Source: cbc.ca